0001209191-19-051167.txt : 20190930 0001209191-19-051167.hdr.sgml : 20190930 20190930212609 ACCESSION NUMBER: 0001209191-19-051167 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190926 FILED AS OF DATE: 20190930 DATE AS OF CHANGE: 20190930 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Goldberg Jeff Marc CENTRAL INDEX KEY: 0001703061 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38137 FILM NUMBER: 191127365 MAIL ADDRESS: STREET 1: C/O AKCEA THERAPEUTICS STREET 2: 55 CAMBRIDGE PARKWAY, STE 100 CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AKCEA THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001662524 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 472608175 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 22 BOSTON WHARF RD STREET 2: 9TH FLOOR CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 617-207-0202 MAIL ADDRESS: STREET 1: 22 BOSTON WHARF RD STREET 2: 9TH FLOOR CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-09-26 1 0001662524 AKCEA THERAPEUTICS, INC. AKCA 0001703061 Goldberg Jeff Marc C/O AKCEA THERAPEUTICS, INC. 22 BOSTON WHARF ROAD, 9TH FLOOR BOSTON MA 02210 0 1 0 0 Chief Operating Officer Common Stock 2019-09-26 4 M 0 302250 6.48 A 305560 D Common Stock 2019-09-26 4 F 0 185122 16.64 D 120438 D Common Stock 2019-09-26 4 M 0 83952 6.48 A 204390 D Common Stock 2019-09-26 4 F 0 52973 16.64 D 151417 D Common Stock 2019-09-26 4 M 0 35230 12.21 A 186647 D Common Stock 2019-09-26 4 F 0 30016 16.64 D 156631 D Stock Option (right to buy) 6.48 2019-09-26 4 M 0 302250 0.00 D 2025-12-15 Common Stock 302250 0 D Stock Option (right to buy) 6.48 2019-09-26 4 M 0 83952 0.00 D 2026-02-16 Common Stock 83952 7633 D Stock Option (right to buy) 12.21 2019-09-26 4 M 0 35230 0.00 D 2027-06-04 Common Stock 35230 17607 D The shares vest as follows: 1/4th of the shares vest one year after January 5, 2015;1/48th of the shares vest monthly thereafter over the next three years. The shares vest as follows: 1/4th of the shares vest one year after January 4, 2016;1/48th of the shares vest monthly thereafter over the next three years. The shares vest as follows: 1/4th of the shares vest one year after January 3, 2017;1/48th of the shares vest monthly thereafter over the next three years. /s/ Jeffrey M. Goldberg 2019-09-30